Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Idefirix (imlifidase) receives provisional approval in Australia as desensitization treatment in highly sensitized patients prior to kidney transplantation

Regulatory milestone marks the first time Idefirix has been approved in kidney transplantation from both living and deceased donorsLund, Sweden, July 11, 2023. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that the Australian Therapeutic Goods Administration (“TGA”) has provisionally approved Idefirix (imlifidase) as desensitization treatment for highly sensitized patients prior to kidney transplantation from both living and deceased donors. The provisional approval has a duration of two years and was

GomSpace and Terma sign a Memorandum of Understanding

The two largest companies in the Danish Space Industry, GomSpace and Terma, have signed an MOU aimed at building a joint offering for an Asian project focusing on monitoring and protection of water territories.GomSpace and Terma have signed an MOU with the objective of developing a turn-key solution for an Asian project for monitoring and protecting the concerned country’s national waters, including its Economic Exclusion zone, against illegal fishing, pollution and other environmental damages. The MOU outlines a contractual framework including activities within design, development,

Peptonic signs license agreement with Prima Lab regarding menopause test

PEPTONIC Medical AB today announced that the company has signed a license agreement with Swiss medical device company Prima Lab SA for the sale of self-tests for measurement of FSH hormone in Sweden.The agreement means that Peptonic gets the right to sell Prima Lab's self-test for FSH hormone under its own brand VagiVital® in Sweden, with a planned launch in early 2024. Today, about one million women in Sweden are in menopause. Menopause brings problems to varying degrees such as vaginal dryness, sweating, hot flushes and more subtle symptoms such as concentration and memory difficulties.

Svenska Aerogel’s innovative product SeaQare[®] is being tested in antifouling coatings in Florida

SeaQare[®], Svenska Aerogel’s advanced technology for antifouling paints, has previously showcased remarkable results in two independent static ocean tests carried out in Sweden. Now the company has expanded testing to international waters, as SeaQare[®] is currently being tested in Florida, United States. The aim of this new test is to demonstrate the product's efficacy in a different geographical and environmental context.“As we venture into the Florida ocean test, we are proud of the positive and sustainable effect that SeaQare® has already demonstrated in Sweden,” said Pernilla Ståhle,

Invitation: Sobi’s Q2 2023 report

Sobi plans to publish its report for the second quarter of 2023 on 18 July 2023 at 08:00 CEST.Investors, analysts and media are invited to participate in a conference call which will include a presentation of the results and a Q&A session on the same day at 13:00 CEST.   The presentation can be followed live here  or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call.   To participate in the conference call, please use the following dial-in details: Sweden:

Safello enters into agreement with Finshark for payment services

Stockholm, 11 July 2023 | Today, Safello, the leading cryptocurrency exchange in the Nordics, entered into an agreement with Finshark, a Swedish open banking company providing Safello with payment initiation services for instant payments and payouts.  As part of Safello's continuous work to solidify its position as a leading cryptocurrency exchange  and mitigate counterparty concentration risks, Safello has further expanded its relationships by entering into agreement with Finshark for payment initiation services.  Finshark is an open banking company and payment service provider,

Invitation to the presentation of Nordnet's interim report January-June 2023

Nordnet invites you to a presentation of the company’s interim report January-June on Tuesday, July 25 at 10:00 a.m. CET. The report will be published the same day at 08:00 CET.CEO Lars-Åke Norling and CFO Lennart Krän will present the results. After the presentation, there will be an opportunity to ask questions to Lars-Åke Norling, Lennart Krän and Head of Investor Relations, Marcus Lindberg. Both the presentation and the Q&A session will be held in English. The presentation is digital and will be broadcast via Zoom. You must register to participate. Please join the presentation a few

Presentation of 2[nd] quarter 2023 results

Atea ASA will present its 2[nd] quarter 2023 financial results on Tuesday, 18 July 2023 at 08:00 CEST. The presentation will be held at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo, Norway. In addition to presenting the 2[nd] quarter 2023 results, the company will provide an update on the business. The quarterly report, presentation material, and webcast will be available at:https://www.atea.com/financial-reports/ For further information, please contact:Robert Giori, CFO, Atea ASA, mobile (+47) 934 09 188  About AteaAtea is the leading supplier of IT infrastructure in

Recipharm’s new analytical lab brings impressive testing capabilities to global markets

Global contract development and manufacturing organisation (CDMO) Recipharm has opened a new analytical lab in Bengaluru, India to enhance its global testing capabilities for nitrosamines, extractables and leachables, and elemental impurity testing. Fully cGMP/cGLP compliant, the 5,000 sq.ft lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers in their research and development of oral solids, drug delivery, inhalation, vaccines and injectables. The investment in the new lab responds to the increasing demand for a trusted

Kindred launches proprietary tech platform in Pennsylvania

Kindred continues the rollout of its proprietary tech platform in North America by launching in Pennsylvania. This follows the successful launch in New Jersey in May. Customers in Pennsylvania were able to access Unibet Casino and Sportsbook apps on the Kindred platform from July 10.Kindred Group plc (Kindred) expands its proprietary platform to Pennsylvania, providing customers with an enhanced experience, personalised content and products, as well as improved analytics. Pennsylvania is a key multi-product market for Kindred, and it’s Unibet brand has been live in the market for over three

Rising through the ranks: Odfjell promotes first female Captain

In July, Lise Henriksen embarks on the next leg of her extraordinary seafaring journey as she boards Bow Sky as Captain. By that, she is writing history in the 109-year-old Norwegian chemical tanker company. "On behalf of Odfjell, I congratulate Lise on her well-deserved promotion and thank her for paving the way for women in the maritime industry. Her expertise and leadership abilities have led her to this prestigious role – a historic appointment at Odfjell and in an international maritime field currently dominated by men. We are thrilled that we have arrived at a goal we have

Intervacc to collaborate with Testa Center to optimise production processes for their prototype vaccine for pigs

Stockholm, July 11, 2023 - Intervacc AB (publ) announces the initiation of a project with Testa Center, Uppsala, to optimise the development of manufacturing processes for a prototype vaccine in pigs. Intervacc’s innovative vaccine technology involves fusing important proteins together in order to protect animals from complex bacterial diseases. The new pig vaccine generated positive results in early proof-of-concept studies where the consumption of colostrum from vaccinated sows provided significant levels of protection to piglets at 4 and 7 weeks of age against meningitis, septicaemia

Pre-stabilisation Period Announcement

11 July 2023 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. EU / ISIN EU000A3K4DT4 Pre-stabilisation Period Announcement Landesbank Baden-Württemberg (contact: Torsten Zittlau; telephone: +49 711 127 74640)hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2014). The securities:

Allurity strengthens its Board of Directors with the addition of senior cybersecurity executive Yolande Young

Allurity, a group of best-in-class tech-enabled cybersecurity companies across Europe, is delighted to announce the appointment of Yolande Young to its board of directors. Yolande's extensive experience and profound expertise in the field of cybersecurity will play an important role in Allurity's exciting growth journey towards becoming a leading cybersecurity services provider in Europe.   As Allurity strives to reach its position as a leader in the cybersecurity industry, Yolande's appointment signifies the company's commitment to bolstering its capabilities and expanding its

iLOQ Sustainability Report 2022 has been published

iLOQ takes a holistic 360-degree approach to sustainability. This means looking at all ESG factors not only in the company’s day-to-day operations, but across the entire supply chain and throughout the lifecycle of its solutions. Continuous development of the circular economy and sustainable performance is an important part of iLOQ’s strategy. iLOQ’s audited sustainability report has been published in English https://www.iloq.com/en/sustainability/ More information Erja Sankari, Chief Operating Officer, erja.sankari@iloq.com, Tel. +358 (0) 44 435 2382 Minna Tuomikoski,

Norse Atlantic Airways Expands Winter Schedule With New Direct Flights From Paris And Berlin to Miami

· From December Norse Atlantic will serve four destinations in Europe from Miami, with Berlin and Paris joining London and Oslo. · Flights from Paris to Miami operate four times a week and start from €219 one way including taxes. · Flights from Berlin to Miami operate once a week and start from €239 one way including taxes.Norse Atlantic Airways, the pioneering low cost transatlantic airline, is pleased to announce the launch of new flights connecting Paris to Miami from 11[th] December 2023 and Berlin to Miami from 15[th] December 2023 as part of its upcoming winter schedule, flights

Alight opens Madrid office to support European expansion

Alight is excited to announce that it is opening an office in Madrid to support the company’s European buildout. This is Alight’s second European office, complementing its headquarters in Stockholm, Sweden.In November 2022, DIF Capital Partners invested €150 million in Alight to accelerate the development of its near-term pipeline of solar projects across Europe, and by 2030, Alight is set to have an installed capacity of at least 5 GW backed with solar power purchase agreements (PPAs). Opening an office in one of Europe’s most mature solar energy markets will allow the company to tap into

Elicera Therapeutics receives Notice of Allowance for European patent protecting the iTANK[TM] platform

Gothenburg, July 11, 2023 – Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing next-generation therapies based on oncolytic viruses and CAR T-cells armed with bystander immune activating properties using the company’s commercially available platform iTANK[TM], today announced that it has received a Communication under Rule 71(3) EPC (“Notice of Allowance”) from the European Patent Office in its European patent application relating to the use of the iTANK[TM] technology in CAR T-cell therapies.The Communication means that the European Patent

Sensys Gatso receives a seven-year TRaaS contract for traffic safety in Bensalem worth SEK 22 million, expanding the footprint in Pennsylvania

Sensys Gatso Group, a global leader in traffic safety solutions, through its subsidiary, Sensys Gatso USA, has executed a seven-year base-term automated red light enforcement contract with the Township of Bensalem, PA. The contract is estimated to be worth up to $2.1 million (USD) corresponding to SEK 22 million. The program will include red light enforcement systems and is anticipated to begin in early fall.William McVey, Director of Public Safety for Bensalem Township Police Department says, “Our goal is to reduce the number of traffic accidents and red light violations at these

Invitation to the presentation of Ratos Interim report January-June 2023

The Interim report January-June 2023 will be released on Wednesday 19 July at 07.00 CEST.At 09.00 CEST will Jonas Wiström, President and CEO, and Jonas Ågrup, CFO, present the report.The presentation can be followed on Youtube via the following link; https://youtube.com/live/7LR1TozAeYg?feature=share  The live presentation will be recorded and is available afterwards via the same link.Participants who wish to ask questions live are asked to pre-register, please send an e-mail to helena.jansson@ratos.com in advance for a personal invitation.The presentation and report will be

SKF Half-year report to be published on 19 July

Gothenburg, 11 July 2023: SKF will publish its Half-year results for 2023 on 19 July at approximately 07:00 (CEST). Investors, analysts, and media are invited to join a webcast, which will be held in English, at 08:15 (CEST). To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. Link to web event: https://www.investis-live.com/skf/648982e267ddff0c002ef682/andn Sweden                                +46 10 884 80 16UK / International                 +44 20 3936 2999Passcode:                            466190 All

Africa Oil Announces an Increase in its Operated Interest in Block 3B/4B

VANCOUVER, BC, July 11, 2023 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“Africa Oil”, “AOC” or the “Company”) is pleased to announce that it has entered an agreement to increase its operated working interest (“WI”) in Block 3B/4B, located in the Orange Basin offshore South Africa and on trend with the Venus, Graff, La Rona and Jonker oil discoveries, for an additional 6.25% interest. An independent review of the prospective resources and probability of geological success of an inventory of exploration prospects within Block 3B/4B, has reported total unrisked gross P50

Invitation to presentation of Bactiguard’s interim report for the second quarter on July 18, 2023

Bactiguard Holding AB (publ) publishes its interim report for the second quarter on Tuesday July 18, 2023 at 08:00 CEST.In connection with this, Bactiguard will host an audiocast for investors, analysts and media at 11:00 CEST. Interim CEO Thomas von Koch will present the report and, together with Carin Jakobson, CFO, answer questions. The report and a presentation will be available at Bactiguard’s website www.bactiguard.com  To participate in the audiocast, please use this link:www.bactiguard.com/report/q2-2023/ To participate only by

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for June 2023

Oslo, Norway, July 11, 2023 Commercial update: In June 2023, the Company achieved average time charter equivalent earnings of approximately US$21,500 per day, gross. The Company’s six vessels trading on index-linked time charter earned approximately US$21,000 per day, gross, including average daily scrubber benefits of approximately US$2,500 per day. The Company’s two vessels trading on fixed time charter earned approximately US$23,000 per day, gross, including scrubber benefits. The Baltic 5TC Capesize Index averaged US$13,247 during June 2023. Cash Distribution: The Board

There are no items matching the current filter
There are no more items matching the current filter
Back to top